SIAG
ARMP icon

Safeguard Investment Advisory Group’s Armata Pharmaceuticals ARMP Stock Holding History

Safeguard Investment Advisory Group’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2
Closed – – 116
2020
Q4 		$0 Buy
+2
New +$6 ﹤0.01% 712

Other funds holding ARMP

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return

Safeguard Investment Advisory Group's ARMP Position: Q1 2021 in Review

Safeguard Investment Advisory Group sold out of Armata Pharmaceuticals (ARMP) in Q1 2021, closing a stake of 2 shares.

Safeguard Investment Advisory Group first reported a position in ARMP in Q4 2020 and held it in 1 quarter. The position peaked at $0 in Q4 2020. 23 funds tracked by Wall St. Rank hold ARMP as of Q1 2021.

  • Safeguard Investment Advisory Group reported no remaining Armata Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Safeguard Investment Advisory Group sold 2 Armata Pharmaceuticals shares in Q1 2021.
  • Safeguard Investment Advisory Group first reported a position in Armata Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Safeguard Investment Advisory Group's Armata Pharmaceuticals position peaked at $0 in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q1 2021.

Based on Safeguard Investment Advisory Group's 13F filing for Q1 2021, filed 10 May 2021.